Camber Capital Management as of March 31, 2014
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 39 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 18.3 | $234M | 1.3M | 187.01 | |
| Teva Pharmaceutical Industries (TEVA) | 6.8 | $87M | 1.7M | 52.84 | |
| WellPoint | 6.2 | $80M | 800k | 99.55 | |
| Tenet Healthcare Corporation (THC) | 5.7 | $73M | 1.7M | 42.81 | |
| Quest Diagnostics Incorporated (DGX) | 5.0 | $64M | 1.1M | 57.92 | |
| CONMED Corporation (CNMD) | 4.7 | $60M | 1.4M | 43.45 | |
| Community Health Systems (CYH) | 3.8 | $49M | 1.3M | 39.17 | |
| Volcano Corporation | 3.8 | $48M | 2.5M | 19.71 | |
| Hca Holdings (HCA) | 3.3 | $42M | 800k | 52.50 | |
| Mallinckrodt Pub | 3.2 | $41M | 650k | 63.41 | |
| Haemonetics Corporation (HAE) | 3.1 | $39M | 1.2M | 32.59 | |
| Laboratory Corp. of America Holdings | 2.9 | $37M | 375k | 98.21 | |
| Masimo Corporation (MASI) | 2.7 | $35M | 1.3M | 27.31 | |
| Hologic (HOLX) | 2.5 | $32M | 1.5M | 21.50 | |
| Universal American | 2.3 | $30M | 4.2M | 7.07 | |
| UnitedHealth (UNH) | 1.9 | $25M | 300k | 81.99 | |
| Ariad Pharmaceuticals | 1.9 | $24M | 3.0M | 8.06 | |
| Abbott Laboratories (ABT) | 1.8 | $23M | 600k | 38.51 | |
| Hill-Rom Holdings | 1.8 | $23M | 600k | 38.54 | |
| Humana (HUM) | 1.8 | $23M | 200k | 112.72 | |
| Keryx Biopharmaceuticals | 1.7 | $21M | 1.3M | 17.04 | |
| Amarin Corporation (AMRN) | 1.6 | $20M | 11M | 1.81 | |
| Genomic Health | 1.6 | $20M | 750k | 26.34 | |
| Bluebird Bio (BLUE) | 1.3 | $16M | 707k | 22.74 | |
| Furiex Pharmaceuticals | 1.0 | $13M | 150k | 87.00 | |
| Tornier Nv | 1.0 | $13M | 614k | 21.22 | |
| Mylan | 1.0 | $12M | 250k | 48.83 | |
| NxStage Medical | 0.8 | $11M | 821k | 12.74 | |
| Novavax | 0.8 | $10M | 2.3M | 4.53 | |
| Geron Corporation (GERN) | 0.8 | $9.8M | 4.7M | 2.09 | |
| Revance Therapeutics (RVNC) | 0.7 | $9.5M | 300k | 31.50 | |
| Protalix BioTherapeutics | 0.7 | $9.2M | 2.0M | 4.58 | |
| GenMark Diagnostics | 0.7 | $9.0M | 908k | 9.94 | |
| Targacept | 0.6 | $7.4M | 1.6M | 4.75 | |
| Sequenom | 0.6 | $7.1M | 2.9M | 2.45 | |
| AngioDynamics (ANGO) | 0.5 | $6.5M | 412k | 15.75 | |
| Biolase Technology | 0.5 | $6.5M | 2.7M | 2.41 | |
| Momenta Pharmaceuticals | 0.4 | $4.7M | 400k | 11.65 | |
| Cross Country Healthcare (CCRN) | 0.2 | $2.5M | 309k | 8.07 |
